The costs of cardiovascular disease in Brazil: a brief economic comment
Balbinotto Neto, Gácomo.; Silva, E.Nunes.da.
Arquivos Brasileiros de Cardiologia 91(4): 198-9 217-8
2008
ISSN/ISBN: 0066-782X PMID: 19009169 Document Number: 617534
Document emailed within 1 workday
Related Documents
Schmidt, K. 1996: The elderly cardiovascular patient in general practice. Health care costs--drugs--economic feasibility Fortschritte der Medizin 114(7): 43-44Flack, J.M.; Casciano, R.; Casciano, J.; Doyle, J.; Arikian, S.; Tang, S.; Arocho, R. 2002: Cardiovascular disease costs associated with uncontrolled hypertension Managed Care Interface 15(11): 28-36
Peabody, J.W.; Shimkhada, R.; Tan, C.; Luck, J. 2005: The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines Health Policy and Planning 20(6): 347-353
Marmot, M.G. 1996: Socio-economic factors in cardiovascular disease Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 14(5): S201-S205
García Rodríguez, J.F.; Mariño Callejo, A.; Lorenzo García, M.V.; de Juan Prego, J.; Díaz Peromingo, J.A.; Sesema Sánchez, P. 1997: Lost opportunities for preventing tuberculosis and derived costs; comment Medicina Clinica 109(2): 45-48
Burgess, E.D.; Carides, G.W.; Gerth, W.C.; Marentette, M.A.; Chabot, I. 2004: Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective Canadian Journal of Cardiology 20(6): 613-618
Malcolm, L. 1990: Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease New Zealand Medical Journal 103(896): 402-404
Wright, S.; Henderson, C.; Thornicroft, G.; Sharac, J.; McCrone, P. 2015: Measuring the economic costs of discrimination experienced by people with mental health problems: development of the Costs of Discrimination Assessment (CODA) Social Psychiatry and Psychiatric Epidemiology 50(5): 787-795
Lipshultz, S.E.; Schaechter, J.; Carrillo, A.; Sanchez, J.; Qureshi, M.Yasir.; Messiah, S.E.; Hershorin, E.R.; Wilkinson, J.D.; Miller, T.L. 2012: Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? Pediatric Endocrinology Reviews: Per 9(4): 698-705
Adamopoulos, P.N.; Boutsicakis, J.; Kodoyianis, S.; Papamichael, C.; Gatos, A.; Makrilakis, K.; Argyros, D.; Adamopoulos, E.; Argyros, G.; Kostis, E. 1990: Blood pressure and other risk factors of cardiovascular disease in two communities with different socio-economic statuses: the Athens study Journal of Human Hypertension 4(4): 344-349
Barros, Z.M.; de Alencar Ximenes, R.A.; Miranda-Filho, D.óc.B.; de Albuquerque, M.d.F.át.P.M.ão.; Melo, H.ís.R.L.; Carvalho, E.H.; Gelenske, T.; Diniz, G.; Bandeira, F. 2010: Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil Metabolic Syndrome and Related Disorders 8(6): 489-497
Rudofsky, G.; van Laak, H.H. 1994: Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy Journal of Cardiovascular Pharmacology 23(Suppl): S22-S25
Angell, A. 1973: Interest Conflict and Political Change in Brazil, for the Liberation of Brazil, Brazil: the people and the Power and Cambão- The Yoke: the Hidden Face of Brazil International Affairs 49(1): 166-167
Angell, A. 1973: Interest Conflict and Political Change in Brazil, for the Liberation of Brazil, Brazil: the people and the Power and Cambão- The Yoke: the Hidden Face of Brazil International Affairs 49(1): 166-167
Hu, D. 2014: Rethinking, comment and query of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults Zhonghua xin xue guan bing za zhi 42(1): 3-5
Sartori, A.M.C.; Vicentine, M.P.; Gryninger, L.íg.C.F.; Soárez, P.C.d.; Novaes, H.M.D. 2015: Polio inactivated vaccine costs into routine childhood immunization in Brazil Revista de Saude Publica 49: 8
Rubin, P. 1973: Updated Hodgkin's disease: B. Curability of localized disease. Comment: The mantle failure: The transdiaphragmatic extension JAMA 223(1): 65-67
Koch, F. 1997: Cardiovascular costs Seminars in Perioperative Nursing 6(3): 162-164
Argumosa, A.; Herranz, J.L. 2000: Economic costs of childhood epilepsy in Spain Revista de Neurologia 30(2): 104-108
Khalemin, I.A.; Kaganovich, E.L.; Bannikov, E.A.; Evsina, P.I. 1981: Determination of the economic costs of syphilis treatment Vestnik Dermatologii i Venerologii 5: 31-32